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In this issue of the Biomedical Journal we uncover how the discovery of tyrosine phos-
phorylation thirty years ago led to the recent development of potent cancer drugs.
Furthermore we learn about the state of the art of surgery for obstructive sleep apnea and
how modern automated hematology could be used to detect various pathologies. Finally
we discuss the risk factors for hospital-acquired Clostridium difficile infection and how to
minimize ultrasonic motor-induced magnetic resonance imaging artifacts.Spotlight on review
Sweet dreams: how mini-invasive surgery tackles
obstructive sleep apnea
“He who sleeps does not sin”, claims a medieval mock syl-
logism, yet more dangers than one could expect linger in
Morpheus' arms. Proof that the bed is not necessarily a safe
harbor is the panel of sleep disordered breathing (SDB) syn-
dromes, ranging from simple snoring to obstructive sleep
apnea (OSA), which consists in the complete or partial
obstruction of the airways during sleep [1]. It is normal for
the overall muscle tone of the body to decrease during sleep,
however, in some cases this can lead to the collapse of the
soft tissues that compose the throat and airways. As a
consequence, breathing is repeatedly reduced or paused for
up to 40 s, causing depletion in blood oxygen saturation.
g Gung University.
ublishing services by Else
s/by-nc-nd/4.0/).{Rochester:MkNi0iPx}. OAS can be transient in the context of
upper respiratory infections causing the swelling of various
tissues in the throat, or chronic. The latter is most common
inmiddle-aged overweight individuals and twice as frequent
inmales (2e4%) than females. Many factors can contribute to
the development of the syndrome, including craniofacial
abnormalities and excessive bulk of soft tissue but also
problems with the neurologic control of the upper airway
musculature [2].
The severity of the possible health repercussions of
chronic OAS is commonly underestimated. OAS leads to
serious daytime sleepiness, which impacts on working abili-
ties, accidents due to lack of attention and a reduction of
overall life quality, but increases also the risk for inner ear
diseases as well as for hypertension and cardiovascular dis-
eases, includingmyocardial infarction [1] and eventually even
for dementia [3].vier B.V. This is an open access article under the CC BY-NC-ND
b i om e d i c a l j o u r n a l 4 2 ( 2 0 1 9 ) 7 5e7 976Continuous positive airway pressure (CPAP) is the stan-
dard first line of treatment for OAS [4]. Patients wear a
facemask by night through which a ventilator continuously
applies light air pressure to keep the airways open. Other
than the inevitable discomfort generated by the device, CPAP
is not always efficient, leaving usually only surgery as an
alternative treatment [4]. Given the multifactorial etiology of
OAS and the complex architecture of the human airways,
this comprises in reality a multitude of possible in-
terventions that have to be carefully selected, eventually
combined and ultimately backed up with additional treat-
ment methods in order to provide a long-term cure.
On these grounds, Li et al. update us in their compre-
hensive review article on the current state of the art in
decision-making between CPAP and surgery but also surgery
procedure types and finally stress the importance of post-
operative integrated treatment [5]. Concerning the decision-
making between CPAP and surgery, the authors emphasize
on the importance of distinguishing obstruction from
collapse, as the first one evinces clear anatomical de-
formities that can be corrected surgically, while collapse
mostly indicates neurological issues rather palliated by
CPAP, without omitting all the exceptions and hybrid
conditions.
Subsequently, the review takes the reader through the
many different types of surgery, clearly stating for which
precise pathological background they are the most appro-
priate. It becomes clear that over the recent years, much effort
towards mini-invasiveness has been made as to preserve
pharyngeal function. Intra-pharyngeal surgery for example
has transited from blunt excision to a differential treatment of
each tissue, such as ablation of adipose tissue, muscle sus-
pension and mucosa preservation. Other recently developed
techniques comprise mini-invasive septoturbinoplasty (MIST)
as a form of nasal surgery and the use of the suspension
technique as a way to minimize soft palate excision during
uvulopalatopharyngoplasty.
Ultimately, the outcomes of the surgery are significantly
enhanced by postoperative integrated treatment, such as the
re-education and strengthening of the muscles and respira-
tion training via oropharyngeal myofunctional therapy, posi-
tional therapy as to favor lateral sleep, weight loss and
cognitive behavior therapy meant to re-acquire a healthy
circadian rhythm.
All in all, it is very clear that OSA is a complex condition
whose many forms and origins necessitate a thorough and
precise preliminary analysis and a tailored strategy both for
surgical correction and additional measures in order to
maximize the benefit of the latter [Fig. 1].Spotlight on original articles
Automated hematology has more than one string to its bow
Although modern automated hematology analyzers are
nowadays part and parcel of any hematology laboratory,
they are mainly used only for cell counts and differential
leukocyte analysis, despite the fact that most machines
allow for the acquisition of way more parameters. Habit,lack of information about the full potential of the devices
and skewed trust between well-trained hematologists and
machines might be at fault [6]. Among the available addi-
tional features are for example is the reticulocyte hemo-
globin content (CHr), a good indicator for iron deficiency. As
for leukocytes, a multitude of characteristics such as elec-
trical impedance, radiofrequency conductivity, volume,
conductivity and scatter (VCS) of up to 105 cells in a few
seconds can be obtained [6]. Various combinations have
already been suggested to serve the detection of viral, bac-
terial and parasitic infections, sepsis, or malignant hema-
tological conditions [7,8]. Patients with acute lymphocytic
leukemia (ALL) or chronic lymphocytic leukemia (CLL) for
instance were shown to display distinct characteristic VCS
profiles [9].
In the present issue, Gaspar et al. propose to further
exploit the technology's potential and investigate if the
obtained data on leukocyte size and structure could be used
to tell reactive from neoplastic cellular proliferations,
focusing on chronic myeloid leukemia (CML) [10]. CML ac-
counts for 15e25% of all adult leukemias and is character-
ized by an abnormal proliferation of mature granulocytes
and their precursors as well as by the fusion gene BCR-ABL1
[11]. As mentioned in our editorial about the history of
tyrosine kinases, the first targeted tyrosine-kinase inhibitor
that succeeded as an FDA-approved drug was imatinib in
2001 for the treatment of CML and has since then massively
improved therapy and patient life quality [12].
The study consists in the comparison of complete blood
counts and VCS data from newly diagnosed CML patients,
CML patients under imatinib treatment, patients with high
neutrophil counts, pregnant women and healthy controls.
Compared to the benign controls, untreated CML patients
exhibited indeed significantly higher mean neutrophil and
monocyte volumes (MNV, MMV), higher mean lymphocyte
scatter (MLS) as well as higher standard deviations of mean
neutrophil volume and conductivity (MNV-SD, MNC-SD).
Without the input of total leucocyte counts, untreated CML
could be distinguished from benign neutrophilia notably via
the combination of MNV and MNC-SD. Upon treatment by
imatinib on the other hand, these values and several other
parameters seemed to normalize, which suggests that moni-
toring their evolution in the course of therapy could serve as
an indicator for treatment efficiency. Moreover, the combined
analysis of the VCS data by two algorithmic approaches
managed to discriminate untreated CML cases against all
other groups.
As the authors point out, rather than supplanting an
expert opinion in the case of a specific diagnostic conjecture,
this type of analysis and many similar ones could be inte-
grated without any extra cost or need for time and more
samples into global routine automated health check-ups.
Any detected anomaly would generate an immediate “elec-
tronic warning flag”, subsequently prompting the medical
personnel to issue further appropriate tests. Furthermore,
aside from the diagnostic value, this would allow for a sta-
tistically valuable collection of standardized data on a
multitude of conditions, which could in turn help to gain
biological insights into both pathogenesis and treatment
time course.
Fig. 1 The complex task of treating obstructive sleep apnea (OSA). OSA is a multifactorial disease with severe possible
consequences on health and life quality. Treatment success depends heavily on the precise identification of the anatomical
origin of the problem, the tailored choice of intervention and the thorough backing-up of surgery by postoperative integrated
treatments. At the surgery level, the recent trend is towards minimal invasiveness and a maximal preservation of
pharyngeal function.
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News and perspectives
30 years of tyrosine phosphorylation
At the occasion of the bestowal of the prestigious 2018
Tang Prize in Biopharmaceutical Science to Tony Hunter,
Brian Druker and John Mendelsohn “for the discovery of
protein tyrosine phosphorylation and tyrosine kinases as
oncogenes, leading to successful targeted cancer thera-
pies”, Jau-Song Yu takes us in his editorial onto a capti-
vating travel through 30 years of history of tyrosine
phosphorylation [13].
The story starts with the discovery of tyrosine phos-
phorylation by Tony Hunter's lab in 1979 and the ensuing
realization that it is key to major transmembrane signal
transmission mechanisms frequently hijacked by tumors
[14]. Immediately flagging them as potential anti-cancer
targets, research subsequently focused on small molecule
inhibitors of oncogenic tyrosine kinases (TK), but the path
from bench to bedside proved to be long. Brian Druker's teamwas the first to succeed with the approval of imatinib for the
treatment of chronic myelogenous leukemia (CML) in 2001
[15]. In parallel, John Mendelsohn and his colleagues worked
on the development of antibodies to block the tyrosine ki-
nase signaling, an equally long but fruitful trail that led to the
release of cetuximab for cancer colon therapy in 2004 [16].
The search for specific TK inhibitors continues undamped,
presently striving to integrate multi-omics and the concept
of personalized medicine in order to optimize the patient's
treatment response.Original articles
Risks and outcomes of Clostridium difficile infection in a
hospital setting
C. difficile is a bad competitor - as long as a healthy micro-
biotum is in place, the pathogen is usually kept in check [17].
However, once the latter is disrupted, as a consequence of
lifestyle or medical treatment, C. difficile can cause persistent
disease ranging from mild diarrhea to life-threatening pseu-
domembraneous colitis [18]. Thereby it has successfully
b i om e d i c a l j o u r n a l 4 2 ( 2 0 1 9 ) 7 5e7 978acquired the infamous title of number one hospital acquired
infection (12,1%) and the global incidence of C. difficile infec-
tion (CDI) is on the rise [19]. Facing the frequency of infection
relapse, fecal microbiota transplantation might be sometimes
the last hope for cure [20]. In their study, Lee et al. aim to
identify risk factors for CDI, the associated mortality rate and
to put forward possible preventionmethods [21]. They observe
that underlying peptic ulcer disease and previous use of
gastric acid inhibitors or third generation cephalosporins for
at least 3 days significantly correlate with CDI. Mortality was
only linked to overall Charlson scores however. The authors
strongly recommend to base CDI treatment rather on Charl-
son scores than CDI-specific parameters, as underlying dis-
eases play an equally important role in the treatment
outcome.
Mean platelet volume measurements could improve the early
diagnosis of acute coronary syndrome
Acute coronary syndrome (ACS) reflects the reduction in blood
flow in the coronary arteries usually after atheroma rupture or
erosion resulting in the formation of a thrombus [22]. The
direct consequence being malfunction and/or necrosis of the
heart muscle, every minute counts in making the correct
diagnosis and starting treatment [23]. Currently, electrocar-
diogram (ECG) characteristics and cardiac Troponin I and T are
the main, yet not foolproof, diagnostic checkpoints. Conse-
quently, additional biomarkers that are fast and easy to obtain
would be beneficial in order to avoid both under- and mis-
diagnoses. ACS is a consequence of atherothrombosis and the
latter involves the activation of platelets, which in turn cor-
relates with an increase in mean platelet volume (MPV) and
immature platelet fraction (IPF). Here, Huang et al. interrogate
the diagnostic value of these two parameters in confirming
ACS [24]. Indeed, according to a retrospect study, both are
higher in ACS patients and MPV could be used as an inde-
pendent predictor of ACS diagnosis.
Description and trouble-shooting of ultrasonic motor-induced
artifacts in magnetic resonance imaging
Combining magnetic resonance imaging (MRI) with robot-
assisted interventions should improve accuracy, stability
and sampling reproducibility targeting during surgery [25].
However, the synergy is challenged by inherent features of the
robot, such as actuators and sensors, which tend to interfere
with the MRI instrument [26]. Ultrasonic motors (USMs) are
nonmagnetic devices optimized for the use in surgical robots
[27,28], yet some limitations due to various image artifacts still
remain [29]. In the present article, Shokrollahi et al. aim at
identifying the type and origin of USM-caused MRI image ar-
tifacts and the means to minimize them [30]. The authors
observe signal voids, pileups, geometric distortions as well as
zipper andmotion artifacts. Aligning the motor shaft with the
bore axis, decreasing slice thickness, augmenting bandwidth
and ultra-short echo time sequences partially corrected
several artifacts.
Advanced ankylosing spondylitis patients display imbalanced
loss of trunk muscle strength
Ankylosing spondylitis (AS) is an incurable auto-inflammatory
systemic rheumatic disease with strong genetic association,notably the HLA-B27 genotype [31], mainly affecting the joints
of the spine and affecting up to 1,8% of the population. Pro-
gressing disease can lead to the ossification of the vertebrae and
the fusion of the spine, severely impacting quality of life.
Decrease of muscle mass and strength are other disease man-
ifestations but also therapeutic targets.
Wang et al. search to characterize the trunk isometric
strength and the ratio of flexor and extensor strength at
varying trunk postures in AS patients at different disease
stages [32]. Patients of the most advanced AS stages displayed
lowest isometric trunk muscle strength as well as greater loss
in extensor than flexor muscle strength. Consequently, the
authors recommend a strengthening program focusing on the
extensor muscles.
General endotracheal anesthesia is suitable for ERCP-assisted
biliary stone removal
Endoscopic retrograde cholangiopancreatography (ERCP) is an
invasive procedure combining upper gastrointestinal endos-
copy and X-rays to treat narrowed or blocked bile and
pancreatic ducts, for instance because of gallstones [33]. Liang
et al. investigate here via a retrospective study the safety, rate
of success and possible complications of performing ERCP-
assisted biliary stone extraction either with conscious, local
sedation (NS) or under general endotracheal anesthesia (GET)
[34]. According to their results, the GET group had a higher
success rate of complete stone extraction with smaller
required rates of contrast injection but a slightly higher risk to
develop pneumonia due to the tracheal intubation after the
procedure. Preventive strategies could further lower the risk
of the latter.Conflicts of interest
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